Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease (Q35170770)

6 August 2017

Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

6 August 2017

0 references

author name string

Wallace JL

series ordinal

1

1 reference

6 August 2017

1 May 2003

1 reference

Digestive and Liver Disease

6 August 2017

1 reference

6 August 2017

35 Suppl 2

1 reference

6 August 2017

S35-40

1 reference

Therapy of inflammatory bowel disease.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Nitric oxide in mucosal defense: a little goes a long way.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Gastrointestinal-sparing anti-inflammatory drugs: The development of nitric oxide-releasing NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Potential cardioprotective actions of no-releasing aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

A diclofenac derivative without ulcerogenic properties

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

In Vivo Antithrombotic Effects of a Nitric Oxide-Releasing Aspirin Derivative, NCX-4016

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Exacerbation of inflammatory bowel disease associated with use of celecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Markedly reduced intestinal toxicity of a diclofenac derivative

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Scavenging effect of 5-aminosalicylic acid on neutrophil-derived oxidants. Possible contribution to the mechanism of action in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Cytokine mRNA expression profiles in rats infected with the intestinal nematode Nippostrongylus brasiliensis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Enhanced anti-inflammatory effects of a nitric oxide–releasing derivative of mesalamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Cytokines in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900050-1

7 January 2021

NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1152/AJPGI.2001.281.3.G654

Identifiers

DOI

10.1016/S1590-8658(03)00050-1

1 reference

6 August 2017

1 reference

PubMed ID

12846442